Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors

Christopher T. Wild, Yingmin Zhu, Ye Na, Fang Mei, Marcus A. Ynalvez, Haiying Chen, Xiaodong Cheng, Jia Zhou

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

N,N-Diphenylamines were discovered as potent and selective EPAC2 inhibitors. A study was conducted to determine the structure-activity relationships in a series of inhibitors of which several compounds displayed submicromolar potencies. Selectivity over the related EPAC1 protein was also demonstrated. Computational modeling reveals an allosteric site that is distinct from the cAMP binding domain shared by both EPAC isoforms, providing a theory with regards to subtype selectivity.

Original languageEnglish (US)
Pages (from-to)460-464
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume7
Issue number5
DOIs
StatePublished - May 12 2016

Fingerprint

Diphenylamine
Allosteric Site
Structure-Activity Relationship
Protein Isoforms
Proteins
erythromycin propionate-N-acetylcysteinate

Keywords

  • Buchwald-Hartwig amination
  • diphenylamines
  • Exchange proteins directly activated by cAMP (EPAC) inhibitors
  • structure-activity relationship

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors. / Wild, Christopher T.; Zhu, Yingmin; Na, Ye; Mei, Fang; Ynalvez, Marcus A.; Chen, Haiying; Cheng, Xiaodong; Zhou, Jia.

In: ACS Medicinal Chemistry Letters, Vol. 7, No. 5, 12.05.2016, p. 460-464.

Research output: Contribution to journalArticle

Wild, Christopher T. ; Zhu, Yingmin ; Na, Ye ; Mei, Fang ; Ynalvez, Marcus A. ; Chen, Haiying ; Cheng, Xiaodong ; Zhou, Jia. / Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors. In: ACS Medicinal Chemistry Letters. 2016 ; Vol. 7, No. 5. pp. 460-464.
@article{3f92e5ad698d41f29d118ddfaadd6c91,
title = "Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors",
abstract = "N,N-Diphenylamines were discovered as potent and selective EPAC2 inhibitors. A study was conducted to determine the structure-activity relationships in a series of inhibitors of which several compounds displayed submicromolar potencies. Selectivity over the related EPAC1 protein was also demonstrated. Computational modeling reveals an allosteric site that is distinct from the cAMP binding domain shared by both EPAC isoforms, providing a theory with regards to subtype selectivity.",
keywords = "Buchwald-Hartwig amination, diphenylamines, Exchange proteins directly activated by cAMP (EPAC) inhibitors, structure-activity relationship",
author = "Wild, {Christopher T.} and Yingmin Zhu and Ye Na and Fang Mei and Ynalvez, {Marcus A.} and Haiying Chen and Xiaodong Cheng and Jia Zhou",
year = "2016",
month = "5",
day = "12",
doi = "10.1021/acsmedchemlett.5b00477",
language = "English (US)",
volume = "7",
pages = "460--464",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors

AU - Wild, Christopher T.

AU - Zhu, Yingmin

AU - Na, Ye

AU - Mei, Fang

AU - Ynalvez, Marcus A.

AU - Chen, Haiying

AU - Cheng, Xiaodong

AU - Zhou, Jia

PY - 2016/5/12

Y1 - 2016/5/12

N2 - N,N-Diphenylamines were discovered as potent and selective EPAC2 inhibitors. A study was conducted to determine the structure-activity relationships in a series of inhibitors of which several compounds displayed submicromolar potencies. Selectivity over the related EPAC1 protein was also demonstrated. Computational modeling reveals an allosteric site that is distinct from the cAMP binding domain shared by both EPAC isoforms, providing a theory with regards to subtype selectivity.

AB - N,N-Diphenylamines were discovered as potent and selective EPAC2 inhibitors. A study was conducted to determine the structure-activity relationships in a series of inhibitors of which several compounds displayed submicromolar potencies. Selectivity over the related EPAC1 protein was also demonstrated. Computational modeling reveals an allosteric site that is distinct from the cAMP binding domain shared by both EPAC isoforms, providing a theory with regards to subtype selectivity.

KW - Buchwald-Hartwig amination

KW - diphenylamines

KW - Exchange proteins directly activated by cAMP (EPAC) inhibitors

KW - structure-activity relationship

UR - http://www.scopus.com/inward/record.url?scp=84969570409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969570409&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.5b00477

DO - 10.1021/acsmedchemlett.5b00477

M3 - Article

VL - 7

SP - 460

EP - 464

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 5

ER -